Texas Permanent School Fund Has $2.95 Million Holdings in ICU Medical, Incorporated (ICUI)

Texas Permanent School Fund raised its stake in ICU Medical, Incorporated (NASDAQ:ICUI) by 6.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,432 shares of the medical instruments supplier’s stock after acquiring an additional 598 shares during the period. Texas Permanent School Fund owned approximately 0.05% of ICU Medical worth $2,950,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the company. Retirement Systems of Alabama increased its stake in shares of ICU Medical by 1.1% in the 2nd quarter. Retirement Systems of Alabama now owns 19,732 shares of the medical instruments supplier’s stock valued at $5,794,000 after purchasing an additional 206 shares during the last quarter. Baird Financial Group Inc. grew its position in ICU Medical by 0.5% during the 2nd quarter. Baird Financial Group Inc. now owns 49,781 shares of the medical instruments supplier’s stock worth $14,618,000 after acquiring an additional 245 shares during the last quarter. United Services Automobile Association grew its position in ICU Medical by 11.1% during the 2nd quarter. United Services Automobile Association now owns 3,095 shares of the medical instruments supplier’s stock worth $909,000 after acquiring an additional 309 shares during the last quarter. Violich Capital Management Inc. grew its position in ICU Medical by 27.6% during the 2nd quarter. Violich Capital Management Inc. now owns 1,537 shares of the medical instruments supplier’s stock worth $451,000 after acquiring an additional 332 shares during the last quarter. Finally, Arizona State Retirement System grew its position in ICU Medical by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 10,579 shares of the medical instruments supplier’s stock worth $3,107,000 after acquiring an additional 379 shares during the last quarter. Institutional investors own 72.93% of the company’s stock.

In other ICU Medical news, VP Thomas D. Mccall sold 11,133 shares of the company’s stock in a transaction dated Friday, August 24th. The stock was sold at an average price of $302.56, for a total value of $3,368,400.48. Following the sale, the vice president now owns 3,018 shares in the company, valued at approximately $913,126.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Virginia Ruth Sanzone sold 787 shares of the company’s stock in a transaction dated Tuesday, August 28th. The shares were sold at an average price of $303.12, for a total value of $238,555.44. Following the completion of the sale, the vice president now owns 1,367 shares in the company, valued at approximately $414,365.04. The disclosure for this sale can be found here. Insiders have sold a total of 711,920 shares of company stock worth $202,651,956 in the last 90 days. 12.50% of the stock is currently owned by corporate insiders.

A number of equities research analysts recently weighed in on ICUI shares. ValuEngine lowered ICU Medical from a “buy” rating to a “hold” rating in a research report on Tuesday, September 18th. TheStreet upgraded ICU Medical from a “c+” rating to a “b+” rating in a research report on Monday, August 20th. Zacks Investment Research lowered ICU Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, July 11th. Finally, BidaskClub upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Friday, September 28th.

Shares of ICUI stock opened at $263.39 on Friday. The firm has a market cap of $5.21 billion, a P/E ratio of 35.33 and a beta of 0.65. ICU Medical, Incorporated has a twelve month low of $180.45 and a twelve month high of $321.70.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Thursday, August 9th. The medical instruments supplier reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $1.82 by $0.84. The business had revenue of $360.46 million for the quarter, compared to analyst estimates of $337.60 million. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. ICU Medical’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.76 EPS. On average, analysts forecast that ICU Medical, Incorporated will post 7.6 earnings per share for the current fiscal year.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: How to Invest in an Index Fund

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply